While CLL and hairy cell leukemia show elevated expression of CD200, mantle cell lymphoma lacks this marker, allowing better differentiation between these different B-cell malignancies, each of which has a different prognosis [50,51]. This evidence concerns the gene CD200 and mantle cell lymphoma.